《新股表現》騰盛博藥(02137.HK)半日收23元 較上市價反覆高3.4%
騰盛博藥-B(02137.HK)暗盤收20.9元較上市價反覆低6%;該股首掛低開3.8%報21.4元,最多跌8.8%至20.3元獲承接,掉頭倒升6.7%高見23.75元,半日收23元,較上市價22.25元,高3.4%,成交5,182萬股,涉資11.47億元。
騰盛是一家總部位於中國及美國仍未有盈利的生物科技公司,是次在港上市共發售1.1158億股,並已引入11個機構爲基石投資者,合共認購5,302.75萬股;10%公開發售獲291倍超購,已啓動回撥機制佔比曾至50%,認購一手中籤率僅5%;股份以招股範圍(21-22.25元)上限定價,料集資淨額約23.34億元。上市聯席保薦人分別爲大摩及瑞銀。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.